Ethyl 5-methylhex-5-enoat

CAS No. 39495-82-4

Ethyl 5-methylhex-5-enoat( —— )

Catalog No. M37387 CAS No. 39495-82-4

Ethyl 5-methylhex-5-enoate can be prepared from ethyl acrylate and isobutylene.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 32 In Stock
25MG 59 In Stock
50MG 80 In Stock
100MG 112 In Stock
200MG 158 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethyl 5-methylhex-5-enoat
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethyl 5-methylhex-5-enoate can be prepared from ethyl acrylate and isobutylene.
  • Description
    Ethyl 5-methylhex-5-enoate can be prepared from ethyl acrylate and isobutylene.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39495-82-4
  • Formula Weight
    156.22
  • Molecular Formula
    C9H16O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC(=O)CCCC(C)=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ac-IEVDIDVEH (TFA)

    Ac-IEVDIDVEH TFA is a short peptide sequence with Ac at the end.

  • Adrenocorticotropic ...

    Adrenocorticotropic Hormone (ACTH) (1-39), rat is a potent melanocortin 2 (MC2) receptor agonist.Peptide fragments of ACTH (1-39) were formed during in vitro incubation of the peptide with membrane preparations. ACTH (1-39) were isolated by high pressure liquid chromatography, and peptide fragments of ACTH (1-39) characterized by determination of amino acid composition and NH2- terminal residue.

  • Ladiratuzumab

    LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.